Product Liability 2019 Year in Review

• Published date: 03 February 2020
• Subject Matter: Class Action,FDA,Class Certification,Appeals,Damages,RICO,Preemption,Summary Judgment,Manufacturers,Wrongful Death,Motion to Dismiss,Breach of Warranty,Abuse of Discretion,Tolling,Interlocutory Appeals,Warning Labels,Failure To Warn,Statute of Repose,Asbestos Litigation,Mesothelioma,Unjust Enrichment,Causation,Reversal,Supply Chain,Asbestos,Bodily Injury,Injury-in-Fact,OxyContin,Diversity Jurisdiction,Mistrial,Public Health,Health and Safety,MA Supreme Judicial Court,Closing Arguments,Pharmaceutical Industry,Opioid,Consumer Protection Laws,Time-Barred Claims
• Author: David Ferrera,Michael Leard,Laura Martin
• Law Firm: Nutter McClennen & Fish LLP